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Abstract
Background: Neurological complications due to reactivation of varicella-zoster virus (VZV) are very uncommon in
immunocompetent patients. Generally a vesicular rash is present on one or more dermatomes, preceding or
following the main manifestation. Few cases are reported in the international literature, but they concern mainly
adult or elderly patients.
Case presentation: A 12-year-old girl was referred to our hospital for persisting headache, cough and rhinitis for
six days. After first examination, diagnosis of anterior sinusitis was made by nasal endoscopy. The day after, the girl
developed psychotic symptoms and altered mental status. Computed tomography (CT) scan was immediately
performed but was unremarkable; lumbar puncture revealed leukocytosis with lymphocytic predominance and
cerebrospinal fluid polymerase chain reaction (PCR) detected varicella-zoster virus DNA. The diagnosis of acute VZV
encephalitis was made. The patient was promptly treated with acyclovir infused intravenously and her clinical
conditions rapidly improved. Tests made did not show any condition of immunosuppression.
Conclusions: Although if rare, reactivation of VZV can occur in immunocompetent children and its complications
can involve central nervous system. Among these complications, meningitis is more common, but cerebral
parenchyma can also be involved leading to a severe medical condition that is defined meningoencephalitis. In
rare cases vesicular rash may be absent; therefore high level of suspicion is required even in those patients in which
suggestive clinical features are not present to guide the diagnosis. Intravenous acyclovir represents the treatment of
choice to obtain a fast clinical response and to prevent the onset of late-term complications.
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Background
Varicella-zoster virus (VZV) is a neurotrophic alpha-
herpesvirus infecting exclusively humans. VZV causes
varicella (chickenpox) during the first infection (usu-
ally in childhood) and then becomes latent in cranial-
nerve and dorsal-root ganglia. It can reactivate after
several years causing zoster (shingles), sometimes
followed by post-herpetic neuralgia. Reactivation
generally occurs in elder population or in immuno-
compromised patients [1]. VZV can cause a wide
spectrum of central nervous system (CNS) manifesta-
tions during first infection or later if reactivation
occurs, such as encephalitis, cerebellitis, meningitis,
vasculitis, stroke, polyneuropathy. The involvement of
CNS can occur without concomitant skin eruption
(zoster sine herpete) [2]. This scenario is uncommon
both in children and in immunocompetent patients
[3]. In this report, we describe a case of encephalitis
due to VZV reactivation without the expression of
vesicular rash in a 12-year-old immunocompetent girl.
Case presentation
A 12-year-old girl was admitted to our hospital for
persisting headache, started six days before. At the
admission she presented also cough and rhinitis; she
referred mild fever (axillary temperature 38 °C) during
the previous days and three episodes of vomit. If at the
beginning the pain was controlled by paracetamol, dur-
ing the last days the headache had become deep,
localized in the frontal region and associated to photo-
phobia, even though at the beginning the pain was
controlled by paracetamol. She had no personal or
familial history of headache. Her medical history was
unremarkable except for an episode of chickenpox
during her infancy. On physical examination vital signs
were stable (heart rate 90 bpm, blood pressure 111/
73 mmHg, temperature 38 °C, GCS 15), the girl
appeared suffering but her general conditions were
good. Central nervous system examination didn’t show
any neurological deficit, Kernings and Brudzinski signs
were negative, she had no neck stiffness. Deep tendons
reflexes were normal. Pupils were equal, round and
reactive to light; accommodation reflex was present.
Nor nystagmus or diplopia was noticed. Clinical exam-
ination of heart, lungs and abdomen was negative. On
the skin no lesions were present. Blood count was in
normal range, reactive C-protein (CRP) and procalci-
tonin (PCT) were negative, liver and renal functions
were preserved. Analgesic and antipyretic treatment
was administered. Nasal endoscopy was performed on
the second day of hospitalization and highlighted a
picture of acute bacterial sinusitis. Antibiotic therapy
was started. The day after the girl developed altered
mental status and psychomotor agitation; the
headache worsened and was accompanied by three
episodes of vomiting events; in few hours the girl
developed drowsiness and became less responsive to
stimuli. Blood tests were repeated but values were
still in normal range. Computed tomography (CT)
was performed immediately but was unremarkable.
Electroencephalogram (EEG) showed “severe alteration
of cortical electrogenesis with exacerbation of diffuse
slow cortical activity, with fronto-temporal predomin-
ance”. Cerebrospinal fluid examination showed in-
creased protein concentration (72 mg/dl), normal
glucose concentration (52 mg/dl; blood glucose
105 mg/dl), lymphocytic pleocytosis (484 white cells/
µL, 79% lymphocytes, 20% monocytes). The findings
were suggestive for viral infection of CNS. Varicella-
zoster virus was detected using polymerase chain
reaction (PCR). The research of genome of herpes
simplex virus 1 and 2, human herpes virus 6, cyto-
megalovirus and Ebstein-Barr virus was negative.
Serological tests showed the presence of IgG vs. VZV
and absence of IgM vs. VZV, confirming the reactiva-
tion of VZV. Immunological screening for HIV was
negative, serum immunoglobulins, T and B lympho-
cytes counts, complement proteins levels were within
normal range for age.
The girl was treated with intravenous acyclovir
10 mg/kg three times a day. During the first day of
antiviral therapy her clinical conditions rapidly im-
proved and the following day she was well oriented,
smiling and quiet, not remembering the events of the
days before. Her headache disappeared completely
after two days. After 2 weeks of treatment, she was
dismissed with oral acyclovir to be continued for 2
weeks more.
EEG was performed again after 3 and 12 days from
the onset of encephalitis, showing progressive im-
provement of cortical activity, but a persistent slow
focal activity in the right temporal region was regis-
tered. Magnetic resonance was performed after 2 days
from the diagnosis of encephalitis and one month
after the discharge and was unremarkable in both
cases. Lumbar puncture was performed again after 14
days of therapy: protein concentration and glucose
level were in normal range, a mild leukocytosis was
still present (40 white cells/µL, with 93% of lympho-
cytes). PCR for VZV at that time was negative.
Discussion and Conclusions
Varicella-zoster virus (VZV) causes two clinically dis-
tinct diseases. Varicella (or chickenpox) is the result
of primary infection, it is extremely contagious and
occurs mainly among preschool and school-aged chil-
dren; the main characteristic is a generalized itchy
vesicular rash. Although in most cases the evolution
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of varicella is benign, complications and atypical
presentations can occur in previously healthy people,
but their incidence is greater in immunocomprom-
ised patients [4]. After primary infection of varicella
or after vaccination, VZV remains latent in the sensory
ganglion cells and can reactivate if cell-mediated immun-
ity declines as a consequence of aging of the patient or for
the onset of an immunosuppressive state. Therefore,
reactivation of VZV is rare in children [5].
It is known that varicella-zoster virus can cause
several CNS disorders, such as meningitis, cerebellitis,
myelitis, vasculitis and stroke-related syndromes. It
was recognized as the second most common virus
causing viral encephalitis, after herpes simplex virus.
This frequency is declining in recent years in some
countries after the introduction of VZV vaccination.
VZV infections of the central nervous system are
generally more frequent in immunocompromised
individuals, but are not exclusive of this group of
patients. In children, the most common CNS compli-
cation is cerebellitis that can develop during primary
infection. In adults, encephalitis and meningitis have
a higher incidence than in children and are usually
subsequent to the reactivation of VZV [2]. In
pediatric age encephalopathy develops almost exclu-
sively after chickenpox and is related to Reye’s syn-
drome or to a process of perivenous inflammation
and demyelination [1]. Neurological vascular compli-
cations are described both in adults and children [6].
Besides, pseudotumor cerebri has also been described
as a rare neurological complication of VZV reactiva-
tion in pediatric age [7]. The reactivation of VZV in im-
munocompetent patients is uncommon, namely in
childhood. Most of cases described in literature involve
adults, both for encephalitis [8] and meningitis, more
often associated with vesicular rash [9, 10].
The absence of vesicular rash preceding or follow-
ing CNS involvement is rare. In a study of CNS
complications of VZV carried in 84 children with
neurological symptoms associated with VZV infection,
only two patients had no rash, despite the diagnosis
of VZV meningitis, confirmed by PCR analysis of the
CFS [3].
The case we described presents peculiar medical
features: encephalitis was caused by reactivation of
VZV in an immunocompetent child, who did not
present the typical rash. Consequently, we decided to
perform a systematic review of the literature on
PubMed database matching words “encephalitis”,
“central nervous system”, “immunocompetent”, and
“varicella zoster”. Of 103 results obtained, we ana-
lyzed title and abstract of all relevant papers, regard-
less of language. We found only two reported cases
of encephalitis due to VZV reactivation in pediatric
patients in absence of waning of immune system
function. A comparison between our case and previ-
ous described ones is showed in Table 1 [11, 12].
Patient described by Chiappini et al. had a younger
age and the authors presume that early primary in-
fection by VZV could be a risk factor for subsequent
reactivation and CNS manifestations. The case we
described and the case reported by Spiegel et al. do
not support this hypothesis. From the analysis of
mentioned cases, previous VZV reactivations do not
seem to represent a risk factor. According to the
cerebrospinal fluid findings, in our patient and in
Spiegel et al. patient the involvement of meninges
support the diagnosis of meningoencephalitis. EEG
was abnormal in all the three patients, proving the
involvement of cerebral parenchyma; neuroimaging
in our patient was unremarkable. Even if meningitis
due to VZV is more common after a primary infec-
tion, some cases of meningitis due to VZV reactiva-
tion in immunocompetent children have been
reported, mainly (but not exclusively) associated to
the presence of vesicular rash [13–15]. In all these
cases any involvement of cerebral parenchyma was
demonstrated and this supports one of unique fea-
ture of our case. To our knowledge, some cases of
CNS infection due to reactivation of VZV in vacci-
nated children have been reported, but genotyping
verification of the vaccine strain was available in a
relatively small number of patients [16–18]. Regard-
less our patient, as the other two showed in the
table, presented varicella during their infancy and
they did not get vaccination.
In our opinion, it is significant to highlight that
none of the three patients discussed showed the ves-
icular rash, therefore we should keep a high level of
suspicion of VZV infection of central nervous system
even in the absence of suggestive diagnostic clinical
features.
In the suspicion of VZV encephalitis, polymerase
chain reaction (PCR) allows the detection of viral
DNA and RNA in CSF samples with high sensitivity
and specificity [19, 20]. Because virus isolation and
detection of intrathecal antibody production usually
need at least 10 days after the onset of symptoms to
be achieved, PCR is the best technique to make a
prompt diagnosis and to start the correct treatment.
Moreover herpesvirus isolation from early CSF is
exceptional [21]. In our patient, positive serum IgG
and negative IgM allow to distinguish a primary
infection from reactivation.
Intravenous acyclovir 10–15 mg/kg every 8 h is the
treatment of choice; the recommended duration is 14
days but if compromised immune system function is
suspected or known, the treatment should be extended
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to 21 days. Many experts recommend adjunct corticoste-
roids if CNS vasculitis is present [22].
Even if rare, reactivation of VZV with subsequent
involvement of central nervous system can occur in
previous healthy people, including children. Vesicular
rash could be absent; therefore high level of suspicion
for VZV infection has to be kept in patients with
clinical, biochemical and instrumental findings sug-
gestive for viral meningoencephalitis. PCR of cerebro-
spinal fluid is the faster tool to achieve a correct
diagnosis and start a prompt therapy. Intravenous
acyclovir is the drug of choice.
Table 1 Reported cases of encephalitis caused by varicella zoster virus reactivation in immunocompetent children
Chiappini et al., 2002 [11] Spiegel et al., 2010 [12] Our patient, 2020
Age and gender 2-year-old boy 14-year-old girl 12-year-old girl
Chickenpox/vaccination
(age)
Chickenpox (4 months) Chickenpox (4 years) Chickenpox (NA)
Previous reactivation No Zoster (10 years) No
Clinical presentation:
-Fever Yes (T 38.5 °C) Yes (T 39.2 °C) Yes (T 38 °C)
-Neurological symptoms
& signs
Frontal headache,
vomiting, disturbed
consciousness, miotic
pupils, tendon reflexes
absent, left ankle clonus,
bilateral Babinski’s
reflexes elicited
Paresthesias and
hyperesthesia at left
limbs, proximal left leg
weakness; severe frontal
and occipital headache,
stiff neck, positive
Brudjinski sign
Severe frontal
headache, vomiting,
photophobia, altered
mental status,
psychomotor agitation.
- Skin rash No No No
CSF:
- white cells/mL Normal 434 484
- protein (mg/dL) Normal 59 72
- glucose (mg/dL) Normal 49 52
- PCR for VZV-DNA Positive Positive Positive
IgG and IgM VZV Serum: IgG +, IgM -
CSF: IgG and IgM -
Serum: IgG +, IgM - Serum: IgG +, IgM -
EEG Findings compatible
with viral encephalitis
Right-hand sided slow
waves, compatible with
right
hemisphere
encephalopathy
Severe alteration of
cortical electrogenesis
with exacerbation of
diffuse slow cortical
activity, with
fronto-temporal
predominance
MRI Bilateral multifocal
changes in white and
gray matter,
predominantly on the
fronto–parietal cortex
4 hyperintense lesions
without enhancement
after gadolinium
injection: 1 in right
thalamus, 1 in right
temporal subcortical
region, 2 in right parietal
subcortical region
Unremarkable
Immunological screening HIV Ab negative; IgG,
IgA, IgM serum levels, B
and T-lymphocyte counts,
NK cell subset counts,
in vitro T-lymphocyte
response to mitogens,
MHC I and II class
molecule-positive cell
counts: normal.
HIV Ab negative; IgG,
IgA, IgM serum levels,
complement studies,
total counts and
functional studies
of T cells: normal.
HIV Ab negative; IgG,
IgA, IgM serum levels,
B and T-lymphocyte
counts
Treatment (days) Acyclovir iv (15 days);
ceftriaxone iv (5 days)
Acyclovir iv (14 days);
methylprednisolone iv
(5 days)
Acyclovir iv (14 days)
followed by oral
acyclovir (14 days)
Sequelae Mild right hemiparesis Left thigh neuralgia No
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